MedPath
TGA Approval

TRIKAFTA 50/25/37.5 elexacaftor 50mg/tezacaftor 25mg/ivacaftor 37.5mg film-coated tablet and ivacaftor 75mg film-coated tablet blister composite pack (372334)

372334

TRIKAFTA 50/25/37.5 elexacaftor 50mg/tezacaftor 25mg/ivacaftor 37.5mg film-coated tablet and ivacaftor 75mg film-coated tablet blister composite pack

Vertex Pharmaceuticals Australia Pty Ltd

November 1, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01349-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01350-1

Active Ingredients

elexacaftor

ivacaftor

tezacaftor

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRIKAFTA 50/25/37.5 elexacaftor 50mg/tezacaftor 25mg/ivacaftor 37.5mg film-coated tablet and ivacaftor 75mg film-coated tablet blister composite pack (372334) - TGA 批准文号 | MedPath